Drug profile · INN
dabigatran etexilate methanesulfonate
PRADAXA
dabigatran etexilate methanesulfonate (PRADAXA) is an FDA-listed pharmaceutical active ingredient.
PMDA: approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — dabigatran etexilate methanesulfonate
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.78
Quick answer
dabigatran etexilate methanesulfonate (PRADAXA) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN dabigatran etexilate methanesulfonate
Brand PRADAXA
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Pipeline programs
Frequently asked questions
What is dabigatran etexilate methanesulfonate?
dabigatran etexilate methanesulfonate (PRADAXA) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for dabigatran etexilate methanesulfonate?
PRADAXA is a marketed brand name for dabigatran etexilate methanesulfonate. Check FDA Drugs@FDA for the current US label holder and prescribing information.